| Primary |
| Asthma |
57.8% |
| Drug Use For Unknown Indication |
11.8% |
| Product Used For Unknown Indication |
7.6% |
| Chronic Obstructive Pulmonary Disease |
4.8% |
| Bronchitis |
2.8% |
| Cough |
2.8% |
| Hypersensitivity |
2.8% |
| Emphysema |
1.8% |
| Dyspnoea |
1.4% |
| Hepatitis C |
1.2% |
| Chest Discomfort |
1.1% |
| Respiratory Disorder |
1.0% |
| Lung Disorder |
0.8% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Sarcoidosis |
0.6% |
| Colon Cancer |
0.3% |
| Multiple Allergies |
0.3% |
| Nasopharyngitis |
0.3% |
| Occupational Asthma |
0.3% |
| Oesophagitis |
0.3% |
|
| Product Quality Issue |
62.7% |
| No Adverse Event |
6.1% |
| Drug Dose Omission |
4.2% |
| Wheezing |
4.0% |
| Drug Ineffective |
3.5% |
| Underdose |
3.2% |
| Product Container Issue |
2.5% |
| Dyspnoea |
2.0% |
| Pharmaceutical Product Complaint |
1.5% |
| Death |
1.3% |
| Wrong Technique In Drug Usage Process |
1.3% |
| Nausea |
1.1% |
| Asthma |
0.9% |
| Urticaria |
0.9% |
| Headache |
0.8% |
| Incorrect Dose Administered |
0.8% |
| Oropharyngeal Pain |
0.8% |
| Rash |
0.8% |
| Throat Irritation |
0.8% |
| Device Malfunction |
0.7% |
|
| Secondary |
| Asthma |
39.0% |
| Drug Use For Unknown Indication |
12.6% |
| Chronic Obstructive Pulmonary Disease |
8.6% |
| Hypersensitivity |
5.9% |
| Emphysema |
4.8% |
| Product Used For Unknown Indication |
4.8% |
| Bronchitis |
4.1% |
| Hypertension |
3.3% |
| Cough |
2.6% |
| Cardiac Disorder |
2.2% |
| Blood Cholesterol Increased |
1.9% |
| Hypothyroidism |
1.9% |
| Depression |
1.5% |
| Sinusitis |
1.5% |
| Arthritis |
1.1% |
| Diabetes Mellitus |
1.1% |
| Bronchial Disorder |
0.7% |
| Dyspnoea |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Immunodeficiency Common Variable |
0.7% |
|
| Product Quality Issue |
28.3% |
| Throat Tightness |
7.1% |
| Wheezing |
7.1% |
| Dysphonia |
6.1% |
| Chronic Obstructive Pulmonary Disease |
5.1% |
| Dyspnoea |
5.1% |
| Drug Ineffective |
4.0% |
| Somnolence |
4.0% |
| Therapeutic Response Decreased |
4.0% |
| Weight Increased |
4.0% |
| Cerebrovascular Accident |
3.0% |
| Enzyme Abnormality |
3.0% |
| Epistaxis |
3.0% |
| Respiratory Tract Congestion |
3.0% |
| Underdose |
3.0% |
| Electrocardiogram Qt Prolonged |
2.0% |
| Glossodynia |
2.0% |
| Hypersensitivity |
2.0% |
| No Adverse Event |
2.0% |
| Pancreatitis |
2.0% |
|
| Concomitant |
| Asthma |
21.4% |
| Product Used For Unknown Indication |
19.9% |
| Drug Use For Unknown Indication |
18.5% |
| Chronic Obstructive Pulmonary Disease |
10.3% |
| Hypertension |
4.0% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Hypersensitivity |
2.6% |
| Pain |
2.5% |
| Depression |
2.0% |
| Blood Cholesterol Increased |
1.7% |
| Nausea |
1.7% |
| Constipation |
1.6% |
| Muscle Spasms |
1.6% |
| Osteoporosis |
1.5% |
| Diabetes Mellitus |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Emphysema |
1.2% |
| Anxiety |
1.2% |
| Hypothyroidism |
1.1% |
| Rheumatoid Arthritis |
1.0% |
|
| Weight Decreased |
9.3% |
| Dyspnoea |
8.3% |
| Vomiting |
8.3% |
| Asthma |
7.0% |
| Drug Ineffective |
6.3% |
| Urinary Tract Infection |
5.7% |
| Weight Increased |
5.7% |
| Wheezing |
5.0% |
| Flushing |
4.3% |
| Dysgeusia |
4.0% |
| Pre-eclampsia |
4.0% |
| Throat Tightness |
4.0% |
| Anaphylactic Reaction |
3.7% |
| Pancreatitis |
3.7% |
| Sepsis |
3.7% |
| Visual Impairment |
3.7% |
| Death |
3.3% |
| Oedema Peripheral |
3.3% |
| Pain |
3.3% |
| Pneumonia |
3.3% |
|
| Interacting |
| Asthma |
50.0% |
| Bipolar Disorder |
25.0% |
| Hiv Infection |
25.0% |
|
| Myocardial Infarction |
50.0% |
| Tremor |
50.0% |
|
